IL6 and breast carcinoma: We showed further that WA can trigger apoptosis and largely inhibit cell migration/invasion of breast cancer cells even after interleukin-6-induced activation of Signal Transducer and Activator of Transcription 3 [26], which should be viewed as a therapeutic advantage because this transcription factor is often hyperactive in human breast cancers.